La Salle St. Investment Advisors, LLC Humacyte, Inc. Transaction History
La Salle St. Investment Advisors, LLC
- $558 Million
- Q3 2025
A detailed history of La Salle St. Investment Advisors, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, La Salle St. Investment Advisors, LLC holds 67,316 shares of HUMA stock, worth $79,432. This represents 0.02% of its overall portfolio holdings.
Number of Shares
67,316
Previous 60,493
11.28%
Holding current value
$79,432
Previous $126,000
7.14%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding HUMA
# of Institutions
157Shares Held
43.2MCall Options Held
383KPut Options Held
490K-
Vanguard Group Inc Valley Forge, PA7.52MShares$8.87 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.14MShares$8.43 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.1MShares$3.65 Million0.0% of portfolio
-
State Street Corp Boston, MA2.41MShares$2.84 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.1MShares$2.47 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $122M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...